Skip to content
AnalystLens
Back to EXELBalance Sheet

Exelixis Shares Outstanding 2011-2027 | EXEL

Annual FY2020–FY2026 · quarterly through Q3 FY2027

Latest annual · FY2026

262.5M

−6.8%YoY vs FY2025Source: 10-KFY2026

From 304.8M in FY2020 to 262.5M in FY2026: 0.9× in 6 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY27254M−7.8%249M−7.9%245M−8.7%Not reported
FY26275M−6.8%270M−5.3%268M−6.2%262M−6.8%
FY25295M285M286M282M
FY21306M+1.4%309M+2.0%309M+1.9%312M+2.2%
FY20302M303M304M305M

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionDeclining
CAGR

−4.9%

FY2020
304.8M
FY2026
262.5M

3 years selected · on the chart

Shares Outstanding History

Year-over-year comparison from 10-K annual reports

  1. 262.5M
YoY changeLargest recent move−9.6%in FY25Latest −6.8%

Shares Outstanding, period by period

PeriodValueChangeSource
FY2026262.5M−6.8%10-K
FY2025281.7M−9.6%10-K
FY2021311.6M+2.2%10-K
FY2020304.8M—10-K

What is shares outstanding?

Shares outstanding is the total number of common shares currently held by all shareholders, including restricted shares.

What is Exelixis's current shares outstanding?

Exelixis (EXEL) annual shares outstanding for 2026 was 262.5M, a 6.83% decline from 2025. Exelixis shares outstanding for the quarter ending October 2, 2026 was 244.7M.

What was Exelixis's shares outstanding in 2025?

Exelixis annual shares outstanding for 2025 was 281.7M, a 9.59% decline from 2021.

What was Exelixis's shares outstanding in 2021?

Exelixis annual shares outstanding for 2021 was 311.6M, a 2.23% increase from 2020.

What is Exelixis's 5-year shares outstanding CAGR?

Exelixis shares outstanding grew at a compound annual growth rate (CAGR) of 3.37% from FY2021 to FY2026, going from 311.6M to 262.5M over 5 years.

Company
Exelixis
Ticker
EXEL
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)